{
    "title": "GlaxoSmithKline steps up battle against Covid-19 with clinical trials of potential vaccine it is developing with French drug maker Sanofi",
    "url": "https://www.dailymail.co.uk/money/markets/article-8695123/GlaxoSmithKline-begins-coronavirus-vaccine-trials.html",
    "date": "2020-09-03",
    "keywords": [
        "vaccine",
        "gsk",
        "sanofi",
        "share",
        "fund",
        "glaxosmithkline",
        "covid19",
        "drug",
        "half",
        "investment",
        "account",
        "fee",
        "battle",
        "maker",
        "earlystage",
        "study",
        "kind",
        "response",
        "year",
        "trial",
        "yearthe",
        "pair",
        "technology",
        "flu",
        "substance",
        "impact",
        "britain",
        "union",
        "number",
        "duo",
        "astrazeneca",
        "synairgen",
        "article",
        "ftse100",
        "oxford",
        "university",
        "latestage",
        "end",
        "october",
        "signoff",
        "emergency",
        "use",
        "russia",
        "sputnik",
        "v",
        "cent",
        "capital",
        "risk",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}